ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The Effect of Pretreatment With Roc on Succinylcholine Myalgias

ClinicalTrials.gov ID: NCT04581395

Public ClinicalTrials.gov record NCT04581395. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 2, 2026, 7:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Effect of Precurarization With Rocuronium on the Incidence and Severity of Succinylcholine-Induced Fasciculations and Myalgias in a High Volume ERCP Center

Study identification

NCT ID
NCT04581395
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Indiana University
Other
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

  • non-pretreated Succinylcholine Other
  • succinylcholine 1 minute after rocuronium pretreatment Drug
  • succinylcholine 2 minutes following rocuronium pretreatment Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 1, 2020
Primary completion
Apr 24, 2023
Completion
Apr 24, 2023
Last update posted
Aug 20, 2024

2020 – 2023

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
indiana University Indianapolis Indiana 46202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04581395, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2024 · Synced May 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04581395 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →